Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says

Obese or overweight patients who took Eli Lilly's retatrutide lost 58 pounds on average, the pharmaceutical company said in a mid-stage clinical trial.

View full article

...

Latest News

Britain's underfunded National Health Service linked to earlier deaths, study says

3 weeks ago

Eli Lilly's weight loss drugs trounce sky-high expectations, boosting the stock

3 weeks ago

Ex-Pfizer employee charged with illegal trading based on unreleased Covid pill trial data

3 weeks ago

CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older

3 weeks ago

Johnson & Johnson sues Biden administration over Medicare drug price negotiations

4 days ago